 Polyethylene Glycols
"Polyethylene Glycols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
| Descriptor ID |
D011092
|
| MeSH Number(s) |
D02.033.455.250.700 D05.750.741 D25.720.741 J01.637.051.720.741
|
| Concept/Terms |
Polyethylene Glycols- Polyethylene Glycols
- Macrogols
- Macrogol
- Polyethylene Glycol
- Glycol, Polyethylene
- Glycols, Polyethylene
- Polyethylene Oxide
- Oxide, Polyethylene
- Oxides, Polyethylene
- Polyethylene Oxides
- Polyethyleneoxide
- Polyethyleneoxides
- Polyoxyethylenes
- Polyoxyethylene
- Tritons
|
Below are MeSH descriptors whose meaning is more general than "Polyethylene Glycols".
Below are MeSH descriptors whose meaning is more specific than "Polyethylene Glycols".
This graph shows the total number of publications written about "Polyethylene Glycols" by people in this website by year, and whether "Polyethylene Glycols" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 1999 | 4 | 4 | 8 | | 2000 | 1 | 2 | 3 | | 2001 | 3 | 4 | 7 | | 2002 | 4 | 1 | 5 | | 2003 | 2 | 2 | 4 | | 2004 | 5 | 4 | 9 | | 2005 | 6 | 10 | 16 | | 2006 | 6 | 4 | 10 | | 2007 | 1 | 8 | 9 | | 2008 | 16 | 11 | 27 | | 2009 | 26 | 11 | 37 | | 2010 | 18 | 9 | 27 | | 2011 | 19 | 5 | 24 | | 2012 | 11 | 15 | 26 | | 2013 | 11 | 7 | 18 | | 2014 | 15 | 18 | 33 | | 2015 | 14 | 8 | 22 | | 2016 | 9 | 7 | 16 | | 2017 | 10 | 13 | 23 | | 2018 | 14 | 3 | 17 | | 2019 | 10 | 9 | 19 | | 2020 | 4 | 8 | 12 | | 2021 | 0 | 7 | 7 | | 2022 | 0 | 12 | 12 | | 2023 | 4 | 10 | 14 | | 2024 | 8 | 6 | 14 | | 2025 | 6 | 6 | 12 | | 2026 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Polyethylene Glycols" by people in Profiles.
-
Han EL, Kim D, Murray AM, Mrksich K, Hamilton AG, Tang S, Yoo S, Zhu AT, Tong ER, Palanki R, Hall ML, Bedingfield SK, Mitchell MJ. High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain. ACS Nano. 2026 Feb 03; 20(4):3807-3820.
-
Battistella A, Linger M, Johnson RD, Overton M, Sallee A, Jain R, Antreasian B, Ding Y, Tan W. Fabrication of polymer blend vascular grafts with enhanced mechanical properties and rapid cell infiltration: influence of micro/nanostructure, polymer composition, and post-processing on pore architecture and bioengineered environment. Biomed Mater. 2025 Oct 31; 20(6).
-
Barnes A, Gaikwad HK, Siegel D, Angarita D, Nebbia M, Anchordoquy T, Bourne D, Stewart M, Yildirim A, Fierro Cota MM, Duffy JT, Haupt BE, Balyasnikova IV, Simberg D. Role of Serum Stability and Lipoprotein Interactions in Lipid Structure-Tumor Accumulation Relationship. ACS Nano. 2025 Oct 21; 19(41):36435-36450.
-
Tanneberger AE, Blomberg R, Kary AD, Lu A, Riches DWH, Magin CM. Biomaterial-based 3D human lung models replicate pathological characteristics of early pulmonary fibrosis. Acta Biomater. 2025 Sep 15; 204:277-292.
-
Ifergan-Azriel L, Bar-Am O, Saar G, Cohen T, Loebel C, Burdick JA, Seliktar D. Interpenetrating Polymer Network Hydrogel Composition Alters Encapsulated MSC Spreading and In Vivo Degradation Behavior. ACS Biomater Sci Eng. 2025 Sep 08; 11(9):5586-5599.
-
Li Y, Jacques S, Gaikwad H, Nebbia M, Banda NK, Holers VM, Tomlinson SA, Scheinman RI, Monte A, Saba L, Lasda E, Hasselberth J, Busquet N, Zelek WM, Moghimi SM, Simberg D. Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors. Sci Adv. 2025 Jul 11; 11(28):eadw1731.
-
Ray S, Jacques S, Ettah U, Dai S, Gaikwad HK, Scheinman RI, Mallela KMG, Simberg D. Magnetic Nanoworm-Based Screening of Yeast Library for Anti-PEG Nanobodies. Mol Pharm. 2025 Aug 04; 22(8):4909-4918.
-
Vadovics M, Zhao W, Daley EF, Lam K, Daly O, Rashid K, Lee HR, Schreiner P, Lundgreen KA, Gaudette BT, Shuvaev VV, Arguiri E, Muramatsu H, Sárközy A, Mdluli T, Xu J, Han X, De Luna N, Castaño D, Bettini E, Ábrahám E, Lipinszki Z, Carlucci G, Bansode AH, Nguyen K, Le TM, Luu T, Muzykantov VR, Bates P, Allman D, Mitchell MJ, Locci M, Radu CG, Heyes J, Pardi N. Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications. Nat Nanotechnol. 2025 Sep; 20(9):1312-1322.
-
Thompson BJ, Saleh LS, Carillion EL, Alper S, Bryant SJ. Damage Associated Molecular Patterns (DAMPs) Mediate the Foreign Body Response to Poly(ethylene glycol) Diacrylate Hydrogels via Toll like Receptors. ACS Biomater Sci Eng. 2025 Jul 14; 11(7):4128-4138.
-
Simberg D, Barenholz Y, Roffler SR, Landfester K, Kabanov AV, Moghimi SM. PEGylation technology: addressing concerns, moving forward. Drug Deliv. 2025 Dec; 32(1):2494775.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|